Abstract
CD4 cell count and plasma HIV RNA level are used to monitor HIV-infected patients in high-income countries, but the applicability in an African context with frequent concomitant infections has only been studied sparsely. Moreover, alternative inexpensive markers are needed in the attempts to roll out antiretroviral treatment in the region. We explored the prognostic strengths of classic and alternative progression markers in this study set in rural Zimbabwe.
Original language | English |
---|---|
Journal | J A I D S |
Volume | 44 |
Issue number | 4 |
Pages (from-to) | 478-83 |
Number of pages | 6 |
ISSN | 1525-4135 |
DOIs | |
Publication status | Published - 2007 |
Keywords
- Adult
- CD4 Lymphocyte Count
- Cohort Studies
- Female
- Follow-Up Studies
- HIV Infections
- HIV-1
- Hemoglobins
- Humans
- Kaplan-Meier Estimate
- Karnofsky Performance Status
- Lymphocyte Count
- Male
- Multivariate Analysis
- Predictive Value of Tests
- Prognosis
- Proportional Hazards Models
- RNA, Viral
- Rural Health
- Schistosomiasis
- Survival Rate
- Zimbabwe